Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss and the inflammatory response following enhancedrecovery primary total hip arthroplasty: A randomised clinical trial

Bone and Joint Journal

Volumn 99B, Issue 11, 2017, Pages 1442-1449

  Xie, J ^a   Hu, Q ^a   Ma, J ^a   Huang, Q ^a   Pei, F ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN; INTERLEUKIN 6; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEMUR HEAD NECROSIS; FOLLOW UP; HUMAN; INFLAMMATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; AGED; BLOOD; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; HEMOSTASIS; HIP REPLACEMENT; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; OPERATIVE BLOOD LOSS; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PROCEDURES; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BIOMARKERS; BLOOD LOSS, SURGICAL; C-REACTIVE PROTEIN; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HEMOSTASIS, SURGICAL; HUMANS; INFLAMMATION; INJECTIONS, INTRAVENOUS; INTERLEUKIN-6; LENGTH OF STAY; MALE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 85033566996     PISSN: 20494394     EISSN: 20494408     Source Type: Journal    
DOI: 10.1302/0301-620X.99B11.BJJ-2017-0488.R1     Document Type: Article

References (37)

1. Claeys MA, Vermeersch N, Haentjens P. Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg 2007;107:397-401.
2. Rajesparan K, Biant LC, Ahmad M, Field RE. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg [Br] 2009-B;91:776-783.
3. Rasouli MR, Maltenfort MG, et al. Blood management after total joint arthroplasty in the United States: 19-year trend analysis. Transfusion 2016;56:1112-1120.
4. Bedard NA, Pugely AJ, Lux NR, et al. Recent trends in blood utilization after primary hip and knee arthroplasty. J Arthroplasty 2017;32:724-727.
5. Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and metaanalysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg [Br] 2011;93-B:39-46.
6. Alshryda S, Sukeik M, Sarda P, et al. A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J 2014;96-B:1005-1015.
7. Yi Z, Bin S, Jing Y, et al. Tranexamic acid administration in primary total hip arthroplasty: A randomized controlled trial of intravenous combined with topical versus single-dose intravenous administration. J Bone Joint Surg [Am] 2016;98:983-991.
8. Lee QJ, Chang WY, Wong YC. Blood-sparing efficacy of oral tranexamic acid in primary total hip arthroplasty. J Arthroplasty 2017;32:139-142.
9. Nishihara S, Hamada M. Does tranexamic acid alter the risk of thromboembolism after total hip arthroplasty in the absence of routine chemical thromboprophylaxis? Bone Joint J 2015;97-B:458-462.
10. Al-Horani RA, Desai UR. Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders. Med Res Rev 2014;34:1168-1216.
11. Xie J, Ma J, Yao H, Yue C, Pei F. Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss after primary total knee arthroplasty without tourniquet: A randomized clinical trial. J Arthroplasty 2016;31:2458-2464.
12. Goobie SM. Tranexamic acid: still far to go. Br J Anaesth 2017;118:293-295.
13. Xie J, Ma J, Yue C, Kang P, Pei F. Combined use of intravenous and topical tranexamic acid following cementless total hip arthroplasty: A randomised clinical trial. Hip Int 2016;26:36-42.
14. Liu X, Zhang X, Chen Y, et al. Hidden blood loss after total hip arthroplasty. J Arthroplasty 2011;26:1100-1105.
15. Blanié A, Bellamy L, Rhayem Y, et al. Duration of postoperative fibrinolysis after total hip or knee replacement: A laboratory follow-up study. Thromb Res 2013;131:6-11.
16. No authors listed. Technical Specifications of Clinical Blood Transfusion. http:// www.nhfpc.gov.cn/zwgkzt/wsbysj/200804/18676.shtml (date last accessed 22 September 2017).
17. Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology 1983;58:277-280.
18. Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery 1962;51:224-232.
19. Ficat RP. Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment. J Bone Joint Surg [Br] 1985;67-B:3-9.
20. Godier A, Roberts I, Hunt BJ. Tranexamic acid: less bleeding and less thrombosis? Crit Care 2012;16:135.
21. Jameson SS, Rymaszewska M, Hui AC, et al. Wound complications following rivaroxaban administration: A multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty. J Bone Joint Surg [Am] 2012;94-A:1554-1558.
22. Zou Y, Tian S, Wang Y, Sun K. Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty. Blood Coagul Fibrinolysis 2014;25:660-664.
23. Ralley FE, Berta D, Binns V, Howard J, Naudie DD. One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. Clin Orthop Relat Res 2010;468:1905-1911.
24. Hourlier H, Fennema P. Single tranexamic acid dose to reduce perioperative morbidity in primary total hip replacement: A randomised clinical trial. Hip Int 2014;24:63-68.
25. Ido K, Neo M, Asada Y, et al. Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg 2000;120:518-520.
26. Shemshaki H, Nourian SM, Nourian N, et al. One step closer to sparing total blood loss and transfusion rate in total knee arthroplasty: A meta-analysis of different methods of tranexamic acid administration. Arch Orthop Trauma Surg 2015;135:573-588.
27. Maniar RN, Kumar G, Singhi T, Nayak RM, Maniar PR. Most effective regimen of tranexamic acid in knee arthroplasty: A prospective randomized controlled study in 240 patients. Clin Orthop Relat Res 2012;470:2605-2612.
28. Hsu CH, Lin PC, Kuo FC, Wang JW. A regime of two intravenous injections of tranexamic acid reduces blood loss in minimally invasive total hip arthroplasty: A prospective randomised double-blind study. Bone Joint J 2015;97-B:905-910.
29. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012;344:3054.
30. Ralley FE, Berta D, Binns V, Howard J, Naudie DD. One intraoperative dose of tranexamic Acid for patients having primary hip or knee arthroplasty. Clin Orthop Relat Res 2010;468:1905-1911.
31. Wang C, Kang P, Ma J, et al. Single-dose tranexamic acid for reducing bleeding and transfusions in total hip arthroplasty: A double-blind, randomized controlled trial of different doses. Thromb Res 2016;141:119-123.
32. Dahuja A, Dahuja G, Jaswal V, Sandhu K. A prospective study on role of tranexamic acid in reducing postoperative blood loss in total knee arthroplasty and its effect on coagulation profile. J Arthroplasty 2014;29:733-735.
33. Aderinto J, Brenkel IJ. Pre-operative predictors of the requirement for blood transfusion following total hip replacement. J Bone Joint Surg [Br] 2004;86-B:970-973.
34. Jimenez JJ, Iribarren JL, Lorente L, et al. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: A case control study followed by a randomized double-blind controlled trial. Crit Care 2007;11:R117.
35. Jiménez JJ, Iribarren JL, Brouard M, et al. Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: A randomized double-blind, dose-dependent, phase IV clinical trial. J Cardiothorac Surg 2011;6:138.
36. Wasko MK, Bobecka-Wesolowska K, Tomasiuk R, Kowalczewski J. Measurement of the inflammatory response in the early postoperative period after hip and knee arthroplasty. Clin Chem Lab Med 2015;53:1785-1792.
37. Soffin EM, YaDeau JT. Enhanced recovery after surgery for primary hip and knee arthroplasty: A review of the evidence. Br J Anaesth 2016;117(Suppl 3):62-72.